Blueprint Medicines
BPMC
#2524
Rank
C$7.87 B
Marketcap
$124.35
Share price
0.81%
Change (1 day)
82.54%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$12.39

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$12.47. In 2022 the company made an earnings per share (EPS) of -$12.68 an increase over its 2021 EPS that were of -$14.89.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.39-2.28%
2022-$12.68-14.85%
2021-$14.89-297.13%
2020$7.56-176.3%
2019-$9.9035.19%
2018-$7.3238.82%
2017-$5.2847.35%
2016-$3.589.25%
2015-$3.28-31.35%
2014-$4.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.09495-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.37-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.72-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA